Kim Tam Bui1,2, Belinda E Kiely3,4,5,6, Haryana M Dhillon7,8, Chris Brown5, Kay Xu6, Mohsen Shafiei9, Prunella Blinman3,4. 1. Medical Oncology, Concord Cancer Centre, 1A Hospital Road, Concord, NSW, 2139, Australia. tam.bui@health.nsw.gov.au. 2. Sydney Medical School, University of Sydney, Sydney, NSW, Australia. tam.bui@health.nsw.gov.au. 3. Medical Oncology, Concord Cancer Centre, 1A Hospital Road, Concord, NSW, 2139, Australia. 4. Sydney Medical School, University of Sydney, Sydney, NSW, Australia. 5. NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia. 6. Medical Oncology, Macarthur Cancer Therapy Centre, Campbelltown, NSW, Australia. 7. Psycho-Oncology Cooperative Research Group, School of Psychology, University of Sydney, Sydney, NSW, Australia. 8. Centre for Medical Psychology & Evidence-Based Decision-Making, University of Sydney, Sydney, NSW, Australia. 9. Medical Oncology, Alan Coates Cancer Centre, Dubbo, NSW, Australia.
Abstract
PURPOSE: Scan-associated anxiety ('scanxiety') is a problem for people with advanced cancer. We aimed to determine the prevalence, severity and associations of scanxiety in this population. METHODS: People with advanced cancer and a computed tomography scan within the last 4 months completed a multicentre survey including self-rated presence (yes/no) and severity (distress thermometer, 0-10) of scanxiety, state anxiety (STAI-6), clinical anxiety and depression (HADS), and fear of progression (FOP-Q-SF). Associations with scanxiety were evaluated. RESULTS: There were 222 participants: mean age 64 years (range 26 to 91), female (61%), most common cancer types (breast 37%, lung 19%, colorectal 16%) and > 1 year since cancer diagnosis (82%). Sixty-two percent had a scan within the last month, and 70% reported waiting > 2 days for the result. Over half (55%) of participants experienced scanxiety. On multivariable analysis, scanxiety was more prevalent in participants who were younger (mean age 62 years with v 66 years without scanxiety, p = 0.02) and more remote (v major city, OR 2.6, p = 0.04). Among participants with scanxiety, the mean severity score was 6 (range 1-10) with peak severity occurring when waiting for scan results. On multivariable analysis, scanxiety was 1.2 points higher in participants who had been diagnosed within the past year (v > 1 year, p = 0.04) and was higher in participants who had higher STAI-6 scores (β = 0.06, p = 0.004). CONCLUSION: Scanxiety is common and can be severe. Strategies to reduce scanxiety are needed.
PURPOSE: Scan-associated anxiety ('scanxiety') is a problem for people with advanced cancer. We aimed to determine the prevalence, severity and associations of scanxiety in this population. METHODS: People with advanced cancer and a computed tomography scan within the last 4 months completed a multicentre survey including self-rated presence (yes/no) and severity (distress thermometer, 0-10) of scanxiety, state anxiety (STAI-6), clinical anxiety and depression (HADS), and fear of progression (FOP-Q-SF). Associations with scanxiety were evaluated. RESULTS: There were 222 participants: mean age 64 years (range 26 to 91), female (61%), most common cancer types (breast 37%, lung 19%, colorectal 16%) and > 1 year since cancer diagnosis (82%). Sixty-two percent had a scan within the last month, and 70% reported waiting > 2 days for the result. Over half (55%) of participants experienced scanxiety. On multivariable analysis, scanxiety was more prevalent in participants who were younger (mean age 62 years with v 66 years without scanxiety, p = 0.02) and more remote (v major city, OR 2.6, p = 0.04). Among participants with scanxiety, the mean severity score was 6 (range 1-10) with peak severity occurring when waiting for scan results. On multivariable analysis, scanxiety was 1.2 points higher in participants who had been diagnosed within the past year (v > 1 year, p = 0.04) and was higher in participants who had higher STAI-6 scores (β = 0.06, p = 0.004). CONCLUSION: Scanxiety is common and can be severe. Strategies to reduce scanxiety are needed.
Authors: Mary K Morreale; Tanina F Moore; Seongho Kim; Heatherlun S Uphold; Lorna M Mabunda; Felicity W K Harper Journal: Patient Educ Couns Date: 2019-08-22
Authors: Joshua M Bauml; Andrea Troxel; C Neill Epperson; Roger B Cohen; Kathryn Schmitz; Carrie Stricker; Lawrence N Shulman; Angela Bradbury; Jun J Mao; Corey J Langer Journal: Lung Cancer Date: 2016-08-16 Impact factor: 5.705
Authors: Peter Herschbach; Petra Berg; Andrea Dankert; Gabriele Duran; Ursula Engst-Hastreiter; Sabine Waadt; Monika Keller; Robert Ukat; Gerhard Henrich Journal: J Psychosom Res Date: 2005-06 Impact factor: 3.006
Authors: Heather M Derry; Paul K Maciejewski; Andrew S Epstein; Manish A Shah; Thomas W LeBlanc; Valerie Reyna; Holly G Prigerson Journal: J Palliat Med Date: 2019-02-06 Impact factor: 2.947
Authors: Kim Tam Bui; Roger Liang; Belinda E Kiely; Chris Brown; Haryana M Dhillon; Prunella Blinman Journal: BMJ Open Date: 2021-05-26 Impact factor: 2.692
Authors: Janna J A O Schoenmaekers; Jeroen Bruinsma; Claire Wolfs; Lidia Barberio; Anita Brouns; Anne-Marie C Dingemans; Lizza E L Hendriks Journal: JTO Clin Res Rep Date: 2022-08-27